Banner Alzheimer’s Institute embraces a three-part mission to:
Set a new national standard of patient and family care
Conduct revolutionary studies in the detection and treatment of Alzheimer’s
Forge scientific collaborations that bring together institutions and disciplines internationally
Setting a new national standard of care
Banner Alzheimer’s Institute has introduced a new standard of care that provides ongoing hope and help for people with Alzheimer’s/dementia and their families. The Banner Alzheimer’s Institute standard of care combines exceptional services, groundbreaking research and innovative programs, including:
Complete medical, neurological and neuropsychological evaluations
Treatment and therapy
Support services that address both medical and non-medical needs
Comprehensive information and resources
Access to promising investigational treatments
Conducting revolutionary studies in the detection and treatment of Alzheimer’s
Our researchers envision, direct and analyze studies that scientists throughout the world regard as pivotal. Our team’s drive to end Alzheimer’s means we may pursue more than two dozen clinical trials at any given time. Our scientists are involved in:
Searching for and then tracking the neurological changes associated with the development of Alzheimer’s
Assessing the value, safety and tolerability of medications targeting Alzheimer’s physical and behavioral symptoms
Evaluating potential therapies that would prevent the onset of Alzheimer’s symptoms
Forging scientific collaborations that bring together institutions and disciplines internationally
Banner Alzheimer’s Institute is proud to partner with scientific, medical, academic and industry partners to end Alzheimer’s disease. Our collaborations include:
Arizona Alzheimer’s Consortium – Banner Alzheimer’s Institute launched and now leads the Arizona Alzheimer’s Consortium, the nation’s foremost model of statewide collaboration in Alzheimer’s disease research.
Alzheimer’s Prevention Initiative – Banner Alzheimer’s Institute championed and now oversees the Alzheimer’s Prevention Initiative (API), an international collaborative. Its goal is to launch a new era of Alzheimer’s prevention research by evaluating the most promising prevention treatments and to do so as quickly as possible. API includes scientists and physicians as well as industry and regulatory agency representatives from throughout the world.
Arizona State University-Banner Neurodegenerative Research Collaborative – Arizona State University (ASU) and Banner Health have formed a new research alliance to advance the scientific study, treatment and prevention of Alzheimer’s, Parkinson’s and other neurodegenerative diseases. This research partnership will include the launch of a new Arizona State University-Banner Neurodegenerative Disease Research Center on ASU’s Tempe campus.